Working… Menu

Abatacept for SLE Arthritis (IM101-330)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02429934
Recruitment Status : Recruiting
First Posted : April 29, 2015
Last Update Posted : April 18, 2019
Bristol-Myers Squibb
Information provided by (Responsible Party):
Bevra Hahn, MD, University of California, Los Angeles

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 1, 2019
Estimated Study Completion Date : December 31, 2019